CUE’s 2023 Market Dance: Down -41.29% – Time to Invest?


A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -41.29%. However, over the last six months, the performance has been stronger by -32.90%. The price of CUE decreased -2.82% over the last 30 days. And in the last five days, it has fallen by -28.90%.

Cue Biopharma Inc’s stock has had a tumultuous market performance. The 1-year high for the company’s stock was $4.89 on 07/17/23, and the lowest price during the same period was recorded at $1.30 on 04/25/24.

52-week price history of CUE Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Cue Biopharma Inc’s current trading price is -68.30% away from its 52-week high, while its distance from the 52-week low is 18.98%. The stock’s price range over this timeframe has been between $1.30 and $4.89. The shares of the Healthcare sector company recorded a trading volume of approximately 0.61 million for the day, which was comparatively higher than the average daily volume of 0.29 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Cue Biopharma Inc (CUE) has experienced a quarterly decline of -31.72% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 75.39M and boasts a workforce of 53 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.1916, with a change in price of -1.3800. Similarly, Cue Biopharma Inc recorded 295,821 in trading volume during the last 100 days, posting a change of -47.10%.

CUE’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CUE stands at 0.43. Similarly, the long-term debt-to-equity ratio is also 0.19.

CUE Stock Stochastic Average

The raw stochastic average for Cue Biopharma Inc over the last 50 days is presently at 25.83%. This reflects a surge from the raw stochastic average of the previous 20 days, which was noted at 25.83%. Further, the company’s Stochastic %K and %D values for the last 20 days were 35.93% and 47.42%, respectively.

Most Popular